Indoco Remedies Ltd
Next 500 2024
+ 9 More
+ 9 More
Share
Share
OVERVIEW
FINANCIALS
About
Indoco Remedies Limited is a pharmaceutical company that manufactures and markets a wide range of pharmaceutical products, including generics, APIs, and formulations. It focuses on delivering high-quality, affordable medicines in various therapeutic areas such as cardiovascular, oncology, and gastroenterology. The company operates globally and has a strong presence in the Indian market.
Incorporation Year: 1947
Headquarters: Mumbai, Maharashtra
Top Management: Mr. S. S. V. D. R. Raghavendra (CEO)
Industry: Pharma
Website: indoco.com
Featured In Fortune India Ranking
Next 500 India
#342(2024)#217(2023)#178(2022)#206(2021)#331(2020)#244(2019)#244(2018)#272(2017)#301(2016)#488(2015)
#342(2024)#217(2023)#178(2022)#206(2021)#331(2020)#244(2019)#244(2018)#272(2017)#301(2016)#488(2015)
Ranking Trend Fortune Next 500 India
Financial Data 2024
Revenue
1,888
(INR Cr)
Net Operating Income
1,817
(INR Cr)
Assets
1,828
(INR Cr)
Profit
98
(INR Cr)
Net Worth
1,110
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1888 13.5% | 1664 6.1% | 1569 24.9% | 1257 12.5% | 1117 16.2% | 961 -7.9% | 1043 -3.4% | 1080 5.8% | 1021 16.3% | 878 19.4% | 735 16.9% | 629 8.0% | 582 16.8% | 499 20.9% | 413 13.3% | 364 - |
| Net Operating Income (INR Cr) | 1817 8.91% | 1669 8.30% | 1541 24.10% | 1242 12.20% | 1107 14.26% | 968 -7.05% | 1042 -3.05% | 1075 6.61% | 1008 17.64% | 857 16.97% | 733 16.14% | 631 0.00% | 569 18.23% | 481 19.62% | 402 13.26% | 355 35.32% |
| Profit (INR Cr) | 98 -30.8% | 142 -8.1% | 155 66.4% | 93 285.8% | 24 - | -3 - | 41 -46.6% | 77 -6.0% | 82 -1.1% | 83 42.8% | 58 35.7% | 43 -7.8% | 46 -9.4% | 51 21.5% | 42 33.9% | 31 - |
| Assets (INR Cr) | 1828 30.4% | 1402 16.8% | 1200 12.1% | 1071 9.6% | 977 -0.3% | 980 0.1% | 979 2.7% | 954 28.9% | 740 15.5% | 640 11.3% | 575 4.4% | 551 8.5% | 508 9.9% | 462 22.7% | 377 12.7% | 334 - |
| Net Worth (INR Cr) | 1110 7.9% | 1028 13.7% | 905 17.6% | 769 13.2% | 680 2.9% | 661 -2.1% | 675 3.6% | 651 13.0% | 577 11.1% | 519 13.5% | 457 10.4% | 414 0.0% | 380 8.5% | 350 12.8% | 311 11.5% | 279 9.5% |
| Employee Cost (INR Cr) | 362 12.2% | 323 8.9% | 296 8.1% | 274 6.8% | 257 10.7% | 232 4.9% | 221 2.0% | 217 19.1% | 182 29.9% | 140 8.1% | 130 20.1% | 108 31.7% | 82 21.8% | 67 26.3% | 53 18.0% | 45 - |
| Interest Cost (INR Cr) | 38 | 25 | 14 | 22 | 26 | 21 | 24 | 6 | 12 | 11 | 19 | 22 | 16 | 4 | 3 | 6 |
| Cash & Bank Balance (INR Cr) | 24 | 13 | 20 | 14 | 38 | 36 | 12 | 63 | 13 | 15 | 13 | 14 | 10 | 24 | 38 | 29 |
| Total Debt (INR Cr) | 672 | 333 | 257 | 267 | 262 | 296 | 282 | 280 | 140 | 97 | 92 | 120 | 114 | 99 | 66 | 56 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 5.2% | 8.6% | 9.9% | 7.4% | 2.2% | - | 4.0% | 7.1% | 8.0% | 9.4% | 7.9% | 6.8% | 8.0% | 10.3% | 10.2% | 8.6% |
| Profit As % Of Assets | 5.4% | 10.2% | 12.9% | 8.7% | 2.5% | - | 4.2% | 8.1% | 11.1% | 12.9% | 10.1% | 7.8% | 9.1% | 11.1% | 11.2% | 9.4% |
| Profit As % Of Networth | 8.9% | 13.8% | 17.1% | 12.1% | 3.6% | - | 6.1% | 11.8% | 14.2% | 16.0% | 12.7% | 10.3% | 12.2% | 14.6% | 13.6% | 11.3% |
| Interest Cost to EBITDA % | 16.1% | 8.8% | 4.3% | 9.9% | 21.3% | 26.8% | 17.4% | 4.0% | 7.3% | 6.4% | 15.7% | 23.6% | 19.3% | 5.2% | 5.4% | 12.7% |
| Debt to Equity Ratio | 0.61 | 0.32 | 0.28 | 0.35 | 0.39 | 0.45 | 0.42 | 0.43 | 0.24 | 0.19 | 0.20 | 0.29 | 0.30 | 0.28 | 0.21 | 0.20 |
| RONW | 9.1% | 14.7% | 18.5% | 12.9% | 3.6% | - | 6.2% | 12.6% | 15.0% | 17.0% | 13.3% | 10.3% | 12.7% | 15.5% | 14.3% | 11.8% |
| ROCE | 10.8% | 16.7% | 22.1% | 15.1% | 5.6% | 1.2% | 7.4% | 11.5% | 16.1% | 19.8% | 16.2% | 12.8% | 13.9% | 14.3% | 13.0% | 12.5% |